| 000 | 01094 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518082742.0 | ||
| 264 | 0 | _c20200924 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a2044-5385 | ||
| 024 | 7 |
_a10.1038/s41408-020-0281-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrara, Felicetto | |
| 245 | 0 | 0 |
_aVenetoclax plus hypomethylating agents or low-dose cytarabine in acute myeloid leukemia: all that glitters is gold? _h[electronic resource] |
| 260 |
_bBlood cancer journal _c01 2020 |
||
| 300 |
_a10 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
| 650 | 0 | 4 |
_aCytarabine _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 773 | 0 |
_tBlood cancer journal _gvol. 10 _gno. 1 _gp. 10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41408-020-0281-x _zAvailable from publisher's website |
| 999 |
_c30571105 _d30571105 |
||